New User:

-or-
Username:
Password:
Forgot your password?
News Breaks
16:11 EDTCYCC
theflyonthewall.com: Cyclacel Pharmaceuticals reports Q3 EPS of (13c) vs. consensus (22c)
Reports Q3 revenue of $200,000 vs. consensus $280,000. :theflyonthewall.com



News For CYCC From The Last 14 Days
Check below for free stories on CYCC the last two weeks.
There are 3 items on the Fly with pertinent information.
Sign up for a free trial to see the rest of the stories you've been missing.
February 4, 2010
09:00 EDTCYCC
theflyonthewall.com: On The Fly: Analysts Initiation Summary

Subscribe for More Information
:theflyonthewall.com
06:25 EDTCYCC
theflyonthewall.com: Cyclacel Pharmaceuticals initiated with a Buy at Roth Capital

Subscribe for More Information
:theflyonthewall.com

January 27, 2010
07:21 EDTCYCC
theflyonthewall.com: Cyclacel Pharmaceuticals regains Nasdaq compliance
Cyclacel Pharmaceuticals announced that NASDAQ notified the Company that it has regained compliance with the minimum $50 million market value of listed securities requirement, and further, that it currently complies with all other applicable standards for continued listing on The NASDAQ Global Market. :theflyonthewall.com